Dissection of corticotropin-releasing factor system involvement in locomotor sensitivity to methamphetamine

Genes, Brain and Behavior

Volumn 10, Issue 1, 2011, Pages 78-89

  Giardino, W J ^a   Pastor, R ^a,b   Anacker, A M J ^a   Spangler, E ^a   Cote, D M ^a   Li, J ^a   Stenzel Poore, M P ^a   Phillips, T J ^a,c   Ryabinin, A E ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITAT JAUME I   (Spain)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Addiction; Amphetamine; Amygdala; Corticotropin releasing hormone; Urocortin

Indexed keywords

BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; LIGAND; METHAMPHETAMINE; PROTEIN FOS; UROCORTIN I; UROCORTIN II; UROCORTIN III;

ADAPTATION; AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; BEHAVIOR; CELL ACTIVATION; CELL NUCLEUS; CONTROLLED STUDY; DRUG SENSITIZATION; FEMALE; GENE DELETION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MOUSE; NERVE CELL; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN FUNCTION; PSYCHOMOTOR ACTIVITY; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORTICOTROPIN-RELEASING HORMONE; FEMALE; GENE DELETION; IMMUNOHISTOCHEMISTRY; MALE; METHAMPHETAMINE; MICE; MICE, INBRED DBA; MICE, KNOCKOUT; MOTOR ACTIVITY; MUTATION; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; UROCORTINS;

MUS;

EID: 78751693522     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2010.00641.x     Document Type: Article

References (80)

1. Atkins, A.L., Helms, M.L., O'Toole, L.A. & Belknap, J.K. (2001) Stereotypic behaviors in mice selectively bred for high and low methamphetamine-induced stereotypic chewing. Psychopharmacology (Berl) 157, 96-104.
2. Bittencourt, J.C., Vaughan, J., Arias, C., Rissman, R.A., Vale, W.W. & Sawchenko, P.E. (1999) Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J Comp Neurol 415, 285-312.
3. Borowsky, B. & Kuhn, C.M. (1991) Monoamine mediation of cocaine-induced hypothalamo-pituitary-adrenal activation. J Pharmacol Exp Ther 256, 204-210.
4. Cador, M., Dumas, S., Cole, B.J., Mallet, J., Koob, G.F., Le Moal, M. & Stinus, L. (1992) Behavioral sensitization induced by psychostimulants or stress: search for a molecular basis and evidence for a CRF-dependent phenomenon. Ann N Y Acad Sci 654, 416-420.
5. Cador, M., Cole, B.J., Koob, G.F., Stinus, L. & Le Moal, M. (1993a) Central administration of corticotropin releasing factor induces long-term sensitization to D-amphetamine. Brain Res 606, 181-186.
6. Cador, M., Dulluc, J. & Mormede, P. (1993b) Modulation of the locomotor response to amphetamine by corticosterone. Neuroscience 56, 981-988.
7. Chalmers, D.T., Lovenberg, T.W. & De Souza, E.B. (1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15, 6340-6350.
8. Chen, A., Perrin, M., Brar, B., Li, C., Jamieson, P., Digruccio, M., Lewis, K. & Vale, W. (2005) Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids. Mol Endocrinol 19, 441-458.
9. Cole, B.J., Cador, M., Stinus, L., Rivier, C., Rivier, J., Vale, W., Le Moal, M. & Koob, G.F. (1990a) Critical role of the hypothalamic pituitary adrenal axis in amphetamine-induced sensitization of behavior. Life Sci 47, 1715-1720.
10. Cole, B.J., Cador, M., Stinus, L., Rivier, J., Vale, W., Koob, G.F. & Le Moal, M. (1990b) Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization. Brain Res 512, 343-346.
11. Coste, S.C., Kesterson, R.A., Heldwein, K.A., Stevens, S.L., Heard, A.D., Hollis, J.H., Murray, S.E., Hill, J.K., Pantely, G.A., Hohimer, A.R., Hatton, D.C., Phillips, T.J., Finn, D.A., Low, M.J., Rittenberg, M.B., Stenzel, P. & Stenzel-Poore, M.P. (2000) Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 24, 403-409.
12. De Vries, T.J., Schoffelmeer, A.N., Tjon, G.H., Nestby, P., Mulder, A.H. & Vanderschuren, L.J. (1996) Mifepristone prevents the expression of long-term behavioural sensitization to amphetamine. Eur J Pharmacol 307, R3-R4.
13. Deroche, V., Piazza, P.V., Maccari, S., Le Moal, M. & Simon, H. (1992) Repeated corticosterone administration sensitizes the locomotor response to amphetamine. Brain Res 584, 309-313.
14. Deroche-Gamonet, V., Sillaber, I., Aouizerate, B., Izawa, R., Jaber, M., Ghozland, S., Kellendonk, C., Le Moal, M., Spanagel, R., Schutz, G., Tronche, F. & Piazza, P.V. (2003) The glucocorticoid receptor as a potential target to reduce cocaine abuse. J Neurosci 23, 4785-4790.
15. Erb, S. & Brown, Z.J. (2006) A role for corticotropin-releasing factor in the long-term expression of behavioral sensitization to cocaine. Behav Brain Res 172, 360-364.
16. Erb, S., Salmaso, N., Rodaros, D. & Stewart, J. (2001) A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 158, 360-365.
17. Erb, S., Funk, D. & Le, A.D. (2003) Prior, repeated exposure to cocaine potentiates locomotor responsivity to central injections of corticotropin-releasing factor (CRF) in rats. Psychopharmacology (Berl) 170, 383-389.
18. Fu, Y., Pollandt, S., Liu, J., Krishnan, B., Genzer, K., Orozco-Cabal, L., Gallagher, J.P. & Shinnick-Gallagher, P. (2007) Long-term potentiation (LTP) in the central amygdala (CeA) is enhanced after prolonged withdrawal from chronic cocaine and requires CRF1 receptors. J Neurophysiol 97, 937-941.
19. Funk, C.K. & Koob, G.F. (2007) A CRF(2) agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats. Brain Res 1155, 172-178.
20. Goeders, N.E. & Clampitt, D.M. (2002) Potential role for the hypothalamo-pituitary-adrenal axis in the conditioned reinforcer-induced reinstatement of extinguished cocaine seeking in rats. Psychopharmacology (Berl) 161, 222-232.
21. Hahn, J., Hopf, F.W. & Bonci, A. (2009) Chronic cocaine enhances corticotropin-releasing factor-dependent potentiation of excitatory transmission in ventral tegmental area dopamine neurons. J Neurosci 29, 6535-6544.
22. Herringa, R.J., Nanda, S.A., Hsu, D.T., Roseboom, P.H. & Kalin, N.H. (2004) The effects of acute stress on the regulation of central and basolateral amygdala CRF-binding protein gene expression. Brain Res Mol Brain Res 131, 17-25.
23. Jamieson, P.M., Li, C., Kukura, C., Vaughan, J. & Vale, W. (2006) Urocortin 3 modulates the neuroendocrine stress response and is regulated in rat amygdala and hypothalamus by stress and glucocorticoids. Endocrinology 147, 4578-4588.
24. Kamens, H.M., Burkhart-Kasch, S., McKinnon, C.S., Li, N., Reed, C. & Phillips, T.J. (2005) Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine. Genes Brain Behav 4, 110-125.
25. Kash, T.L., Nobis, W.P., Matthews, R.T. & Winder, D.G. (2008) Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process. J Neurosci 28, 13856-13865.
26. Koob, G.F. (2008) Corticotropin-releasing factor, neuroplasticity (sensitization), and alcoholism. Proc Natl Acad Sci U S A 105, 8809-8810.
27. Koob, G.F. & Cador, M. (1993) Psychomotor stimulant sensitization: the corticotropin-releasing factor-steroid connection. Commentary on Wise and Leeb "Psychomotor-stimulant sensitization: a unitary phenomenon?". Behav Pharmacol 4, 351-354.
28. Koob, G.F. & Le Moal, M. (2008) Addiction and the brain antireward system. Annu Rev Psychol 59, 29-53.
29. Kozicz, T. (2003) Neurons colocalizing urocortin and cocaine and amphetamine-regulated transcript immunoreactivities are induced by acute lipopolysaccharide stress in the Edinger-Westphal nucleus in the rat. Neuroscience 116, 315-320.
30. Kozicz, T., Yanaihara, H. & Arimura, A. (1998) Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol 391, 1-10.
31. Kozicz, T., Tilburg-Ouwens, D., Faludi, G., Palkovits, M. & Roubos, E. (2008) Gender-related urocortin 1 and brain-derived neurotrophic factor expression in the adult human midbrain of suicide victims with major depression. Neuroscience 152, 1015-1023.
32. Krishnan, B., Centeno, M., Pollandt, S., Fu, Y., Genzer, K., Liu, J., Gallagher, J.P. & Shinnick-Gallagher, P. (2010) Dopamine receptor mechanisms mediate corticotropin-releasing factor-induced long-term potentiation in the rat amygdala following cocaine withdrawal. Eur J Neurosci 31, 1027-1042.
33. Kuperman, Y., Issler, O., Regev, L., Musseri, I., Navon, I., Neufeld-Cohen, A., Gil, S. & Chen, A. (2010) Perifornical Urocortin-3 mediates the link between stress-induced anxiety and energy homeostasis. Proc Natl Acad Sci U S A 107, 8393-8398.
34. Lewis, K., Li, C., Perrin, M.H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T.M., Gulyas, J., Fischer, W., Bilezikjian, L., Rivier, J., Sawchenko, P.E. & Vale, W.W. (2001) Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A 98, 7570-7575.
35. Li, C., Vaughan, J., Sawchenko, P.E. & Vale, W.W. (2002) Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J Neurosci 22, 991-1001.
36. Liu, J., Yu, B., Orozco-Cabal, L., Grigoriadis, D.E., Rivier, J., Vale, W.W., Shinnick-Gallagher, P. & Gallagher, J.P. (2005) Chronic cocaine administration switches corticotropin-releasing factor2 receptor-mediated depression to facilitation of glutamatergic transmission in the lateral septum. J Neurosci 25, 577-583.
37. Lovenberg, T.W., Liaw, C.W., Grigoriadis, D.E., Clevenger, W., Chalmers, D.T., De Souza, E.B. & Oltersdorf, T. (1995) Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci U S A 92, 836-840.
38. Lu, L., Liu, Z., Huang, M. & Zhang, Z. (2003) Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes. J Neurochem 84, 1378-1386.
39. Marinelli, M., Rouge-Pont, F., De Jesus-Oliveira, C., Le Moal, M. & Piazza, P.V. (1997) Acute blockade of corticosterone secretion decreases the psychomotor stimulant effects of cocaine. Neuropsychopharmacology 16, 156-161.
40. Merchenthaler, I., Vigh, S., Petrusz, P. & Schally, A.V. (1982) Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain. Am J Anat 165, 385-396.
41. Moffett, M.C. & Goeders, N.E. (2007) CP-154, 526, a CRF type-1 receptor antagonist, attenuates the cue-and methamphetamine-induced reinstatement of extinguished methamphetamine-seeking behavior in rats. Psychopharmacology (Berl) 190, 171-180.
42. Morgan, J.I., Cohen, D.R., Hempstead, J.L. & Curran, T. (1987) Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237, 192-197.
43. Muglia, L., Jacobson, L., Dikkes, P. & Majzoub, J.A. (1995) Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 373, 427-432.
44. Neufeld-Cohen, A., Evans, A.K., Getselter, D., Spyroglou, A., Hill, A., Gil, S., Tsoory, M., Beuschlein, F., Lowry, C.A., Vale, W. & Chen, A. (2010) Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits. Mol Psychiatry 15, 339, 426-441.
45. NIDA (2006) Methamphetamine Abuse and Addiction. NIDA Research Report Series, 1-8.
46. Palmer, A.A., Verbitsky, M., Suresh, R., Kamens, H.M., Reed, C.L., Li, N., Burkhart-Kasch, S., McKinnon, C.S., Belknap, J.K., Gilliam, T.C. & Phillips, T.J. (2005) Gene expression differences in mice divergently selected for methamphetamine sensitivity. Mamm Genome 16, 291-305.
47. Pastor, R., McKinnon, C.S., Scibelli, A.C., Burkhart-Kasch, S., Reed, C., Ryabinin, A.E., Coste, S.C., Stenzel-Poore, M.P. & Phillips, T.J. (2008) Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: a urocortin1-independent mechanism. Proc Natl Acad Sci U S A 105, 9070-9075.
48. Perrin, M.H., Sutton, S.W., Cervini, L.A., Rivier, J.E. & Vale, W.W. (1999) Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. J Pharmacol Exp Ther 288, 729-734.
49. Phillips, T.J., Dickinson, S. & Burkhart-Kasch, S. (1994) Behavioral sensitization to drug stimulant effects in C57BL/6J and DBA/2J inbred mice. Behav Neurosci 108, 789-803.
50. Piazza, P.V., Maccari, S., Deminiere, J.M., Le Moal, M., Mormede, P. & Simon, H. (1991) Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci U S A 88, 2088-2092.
51. Piazza, P.V., Marinelli, M., Jodogne, C., Deroche, V., Rouge-Pont, F., Maccari, S., Le Moal, M. & Simon, H. (1994) Inhibition of corticosterone synthesis by Metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res 658, 259-264.
52. Pollandt, S., Liu, J., Orozco-Cabal, L., Grigoriadis, D.E., Vale, W.W., Gallagher, J.P. & Shinnick-Gallagher, P. (2006) Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA. Eur J Neurosci 24, 1733-1743.
53. Pringle, R.B., Mouw, N.J., Lukkes, J.L. & Forster, G.L. (2008) Amphetamine treatment increases corticotropin-releasing factor receptors in the dorsal raphe nucleus. Neurosci Res 62, 62-65.
54. Przegalinski, E., Filip, M., Frankowska, M., Zaniewska, M. & Papla, I. (2005) Effects of CP 154, 526, a CRF1 receptor antagonist, on behavioral responses to cocaine in rats. Neuropeptides 39, 525-533.
55. Reyes, T.M., Lewis, K., Perrin, M.H., Kunitake, K.S., Vaughan, J., Arias, C.A., Hogenesch, J.B., Gulyas, J., Rivier, J., Vale, W.W. & Sawchenko, P.E. (2001) Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A 98, 2843-2848.
56. Richter, R.M. & Weiss, F. (1999) In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 32, 254-261.
57. Rivet, J.M., Stinus, L., LeMoal, M. & Mormede, P. (1989) Behavioral sensitization to amphetamine is dependent on corticosteroid receptor activation. Brain Res 498, 149-153.
58. Roberts, A.J., Lessov, C.N. & Phillips, T.J. (1995) Critical role for glucocorticoid receptors in stress- and ethanol-induced locomotor sensitization. J Pharmacol Exp Ther 275, 790-797.
59. Robinson, T.E. & Berridge, K.C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18, 247-291.
60. Sarnyai, Z., Hohn, J., Szabo, G. & Penke, B. (1992) Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats. Life Sci 51, 2019-2024.
61. Sarnyai, Z., Biro, E. & Telegdy, G. (1993) Cocaine-induced elevation of plasma corticosterone is mediated by different neurotransmitter systems in rats. Pharmacol Biochem Behav 45, 209-214.
62. Sarnyai, Z., Biro, E., Gardi, J., Vecsernyes, M., Julesz, J. & Telegdy, G. (1995) Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Brain Res 675, 89-97.
63. Scholl, J.L., Feng, N., Watt, M.J., Renner, K.J. & Forster, G.L. (2009) Individual differences in amphetamine sensitization, behavior and central monoamines. Physiol Behav 96, 493-504.
64. Sinha, R. (2001) How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl) 158, 343-359.
65. Smart, D., Coppell, A., Rossant, C., Hall, M. & McKnight, A.T. (1999) Characterisation using microphysiometry of CRF receptor pharmacology. Eur J Pharmacol 379, 229-235.
66. Sommer, W.H., Rimondini, R., Hansson, A.C., Hipskind, P.A., Gehlert, D.R., Barr, C.S. & Heilig, M.A. (2008) Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence. Biol Psychiatry 63, 139-145.
67. Spangler, E., Cote, D.M., Anacker, A.M., Mark, G.P. & Ryabinin, A.E. (2009) Differential sensitivity of the perioculomotor urocortin-containing neurons to ethanol, psychostimulants and stress in mice and rats. Neuroscience 160, 115-125.
68. Swerdlow, N.R., Vaccarino, F.J., Amalric, M. & Koob, G.F. (1986) The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings. Pharmacol Biochem Behav 25, 233-248.
69. Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J.M., Stalla, G.K., Blanquet, V., Steckler, T., Holsboer, F. & Wurst, W. (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 19, 162-166.
70. Van Pett, K., Viau, V., Bittencourt, J.C., Chan, R.K., Li, H.Y., Arias, C., Prins, G.S., Perrin, M., Vale, W. & Sawchenko, P.E. (2000) Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428, 191-212.
71. Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M.H., Lewis, K., Sutton, S., Chan, R., Turnbull, A.V., Lovejoy, D., Rivier, C., River, J., Sawchenko, P.E. & Vale, W. (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378, 287-292.
72. Vetter, D.E., Li, C., Zhao, L., Contarino, A., Liberman, M.C., Smith, G.W., Marchuk, Y., Koob, G.F., Heinemann, S.F., Vale, W. & Lee, K.F. (2002) Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior. Nat Genet 31, 363-369.
73. Vezina, P., Lorrain, D.S., Arnold, G.M., Austin, J.D. & Suto, N. (2002) Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J Neurosci 22, 4654-4662.
74. Vuong, S.M., Oliver, H.A., Scholl, J.L., Oliver, K.M. & Forster, G.L. (2009) Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF(2) receptor antagonism. Behav Brain Res 208, 278-281.
75. Wang, B., You, Z.B., Rice, K.C. & Wise, R.A. (2007) Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat. Psychopharmacology (Berl) 193, 283-294.
76. Wei, Q., Lu, X.Y., Liu, L., Schafer, G., Shieh, K.R., Burke, S., Robinson, T.E., Watson, S.J., Seasholtz, A.F. & Akil, H. (2004) Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability. Proc Natl Acad Sci U S A 101, 11851-11856.
77. Weninger, S.C., Peters, L.L. & Majzoub, J.A. (2000) Urocortin expression in the Edinger-Westphal nucleus is up-regulated by stress and corticotropin-releasing hormone deficiency. Endocrinology 141, 256-263.
78. Yamamoto, H., Imai, K., Kamegaya, E., Takamatsu, Y., Irago, M., Hagino, Y., Kasai, S., Shimada, K., Yamamoto, T., Sora, I., Koga, H. & Ikeda, K. (2006) Repeated methamphetamine administration alters expression of the NMDA receptor channel epsilon2 subunit and kinesins in the mouse brain. Ann N Y Acad Sci 1074, 97-103.
79. Zorrilla, E.P., Valdez, G.R. & Weiss, F. (2001) Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berl) 158, 374-381.
80. Zorrilla, E.P., Valdez, G.R., Nozulak, J., Koob, G.F. & Markou, A. (2002) Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat. Brain Res 952, 188-199.